CLINICAL CORNER

UPDATE – Liquid Docusate

The Centers for Disease Control (CDC) is continuing the investigation into a multistate outbreak of infections caused by Burkholderia cepacia that may be linked to contaminated liquid docusate (Colace).  At this time, the CDC recommends that clinicians should not recommend the use of any liquid docusate productsThis recommendation has been expanded to all patient populations.

 If a stool softener is needed and the patient is unable to swallow pills, an alternative would be to use a docusate 100 mg gelcap.  The gelcap can be punctured and the contents added to food.  Please note that this will not provide an accurate dose of docusate because much of it will remain adhered to the gelcap wall.

Please contact Kimberly Griego, PharmD at KGriego@contractpharmacy.com or 267-487-9033 with any questions.

Footer Logo

CONTACT US